NC
VRTX icon

Nicholas Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Nicholas Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,510
Closed -$7.21M – 238
2020
Q4 		$7.21M Buy
30,510
+50
+0.2% +$11.5K 0.14% 176
2020
Q3 		$8.29M Buy
30,460
+30
+0.1% +$8.28K 0.17% 134
2020
Q2 		$8.83M Sell
30,430
-4,545
-13% -$1.23M 0.2% 122
2020
Q1 		$8.32M Sell
34,975
-115
-0.3% -$26.4K 0.24% 107
2019
Q4 		$7.68M Sell
35,090
-50
-0.1% -$10.1K 0.16% 142
2019
Q3 		$5.95M Hold
35,140
– – 0.13% 166
2019
Q2 		$6.44M Sell
35,140
-90
-0.3% -$15.7K 0.14% 155
2019
Q1 		$6.48M Hold
35,230
– – 0.15% 152
2018
Q4 		$5.84M Hold
35,230
– – 0.15% 155
2018
Q3 		$6.79M Buy
35,230
+5,130
+17% +$913K 0.15% 154
2018
Q2 		$5.12M Buy
30,100
+2,910
+11% +$451K 0.12% 187
2018
Q1 		$4.43M Buy
+27,190
New +$4.44M 0.1% 188
2017
Q1 		– Sell
-71,865
Closed -$5.29M – 222
2016
Q4 		$5.29M Buy
71,865
+35
+0% +$2.85K 0.12% 143
2016
Q3 		$6.26M Sell
71,830
-85
-0.1% -$8.03K 0.14% 120
2016
Q2 		$6.19M Hold
71,915
– – 0.12% 114
2016
Q1 		$5.72M Buy
71,915
+27,880
+63% +$2.52M 0.12% 115
2015
Q4 		$5.54M Buy
44,035
+2,000
+5% +$241K 0.1% 123
2015
Q3 		$4.38M Buy
42,035
+3,000
+8% +$385K 0.08% 138
2015
Q2 		$4.82M Buy
39,035
+14,515
+59% +$1.83M 0.08% 140
2015
Q1 		$2.89M Buy
+24,520
New +$2.94M 0.05% 196

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Nicholas Company's VRTX Position: Q1 2021 in Review

Nicholas Company sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 30,510 shares — an estimated $7.21M sold.

Nicholas Company first reported a position in VRTX in Q1 2015 and held it in 20 quarters. The position peaked at $8.83M in Q2 2020. 999 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

  • Nicholas Company reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Nicholas Company sold 30,510 Vertex Pharmaceuticals shares in Q1 2021, an estimated $7.21M.
  • Nicholas Company first reported a position in Vertex Pharmaceuticals in Q1 2015 and held it in 20 quarters.
  • Nicholas Company's Vertex Pharmaceuticals position peaked at $8.83M in Q2 2020.
  • 999 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on Nicholas Company's 13F filing for Q1 2021, filed 14 May 2021.